Researchers at UC San Diego say they recently uncovered new insights into a protein that has emerged as a potential molecular “switch” that may determine whether Alzheimer’s-like brain changes lead to ...
The idea is straightforward: Take a blood test now, even without symptoms, and learn if you could some day develop ...
Some brains resist Alzheimer's, even when the disease is already present. Researchers at the Netherlands Institute for ...
Should you receive a diagnosis of AD, many factors shape how symptoms unfold. The brain, even when under siege, retains an ...
A common blood test marker may reveal Alzheimer’s risk years in advance. Elevated immune cells could signal danger early and ...
Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...
Alzheimer’s & Brain Awareness Month in June is a time not just for reflection, but for action, writes guest columnist ...
A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...
The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in ...
A new study indicates ‘we can identify those that are susceptible to Alzheimer’s disease and give them this peptide [therapy] ...
A new study has found comprehensive evidence that "weight-loss" GLP-1 receptor agonists such as semaglutide are effective in ...
STING" molecular switch drives Alzheimer's brain inflammation. Blocking this switch protects synapses in new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results